Miracll Chemicals Co.,Ltd
SZSE:300848.SZ
20.48 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,658.43 | 1,475.145 | 1,475.063 | 1,297.753 | 756.862 | 648.518 | 591.605 | 526.375 | 334.512 | 219.728 | 161.78 | 92 |
| Cost of Revenue
| 1,444.364 | 1,268.003 | 1,274.765 | 1,093.653 | 593.399 | 490.87 | 480.693 | 430.669 | 269.243 | 178.067 | 140.463 | 81.672 |
| Gross Profit
| 214.066 | 207.142 | 200.298 | 204.1 | 163.462 | 157.648 | 110.912 | 95.706 | 65.269 | 41.661 | 21.317 | 10.329 |
| Gross Profit Ratio
| 0.129 | 0.14 | 0.136 | 0.157 | 0.216 | 0.243 | 0.187 | 0.182 | 0.195 | 0.19 | 0.132 | 0.112 |
| Reseach & Development Expenses
| 91.003 | 72.825 | 70.329 | 56.39 | 32.252 | 23.73 | 21.398 | 37.215 | 27.361 | 7.929 | 6.628 | 3.246 |
| General & Administrative Expenses
| 17.126 | 16.993 | 13.771 | 10.347 | 5.767 | -3.106 | -0.623 | -19.91 | -11.373 | 5.937 | 1.001 | 0.558 |
| Selling & Marketing Expenses
| 9.737 | 7.245 | 13.801 | 11.447 | 9.569 | 24.837 | 18.239 | 17.102 | 13.982 | 8.464 | 4.82 | 3.211 |
| SG&A
| 26.863 | 24.238 | 27.573 | 21.795 | 15.336 | 21.732 | 17.616 | -2.808 | 2.609 | 14.402 | 5.821 | 3.769 |
| Other Expenses
| 23.837 | 20.051 | -0.784 | -0.37 | 0.489 | -3.113 | -2.385 | 3.236 | 1.45 | 1.227 | 0.054 | -0.013 |
| Operating Expenses
| 141.703 | 117.113 | 106.07 | 87.699 | 51.807 | 62.379 | 52.444 | 45.921 | 35.345 | 26.342 | 15.962 | 8.573 |
| Operating Income
| 72.363 | 90.029 | 112.071 | 131.267 | 116.209 | 96.801 | 60.19 | 48.913 | 30.401 | 15.626 | 5.507 | 1.459 |
| Operating Income Ratio
| 0.044 | 0.061 | 0.076 | 0.101 | 0.154 | 0.149 | 0.102 | 0.093 | 0.091 | 0.071 | 0.034 | 0.016 |
| Total Other Income Expenses Net
| -0.356 | -0.273 | -0.784 | -0.37 | -0.012 | -1.08 | 0.509 | 2.354 | 1.45 | 1.214 | 0.04 | 0.005 |
| Income Before Tax
| 72.007 | 89.756 | 111.286 | 130.897 | 116.197 | 95.722 | 60.7 | 51.266 | 31.851 | 16.84 | 5.547 | 1.464 |
| Income Before Tax Ratio
| 0.043 | 0.061 | 0.075 | 0.101 | 0.154 | 0.148 | 0.103 | 0.097 | 0.095 | 0.077 | 0.034 | 0.016 |
| Income Tax Expense
| 1.473 | 1.652 | 0.457 | 11.573 | 14.166 | 12.358 | 5.326 | 6.856 | 4.63 | 2.747 | 2.077 | 0.378 |
| Net Income
| 77.588 | 87.864 | 111.283 | 119.147 | 102.032 | 83.364 | 55.374 | 44.41 | 27.221 | 14.095 | 3.472 | 1.086 |
| Net Income Ratio
| 0.047 | 0.06 | 0.075 | 0.092 | 0.135 | 0.129 | 0.094 | 0.084 | 0.081 | 0.064 | 0.021 | 0.012 |
| EPS
| 0.19 | 0.22 | 0.37 | 0.4 | 0.34 | 0.28 | 0.25 | 0.2 | 0.12 | 0.1 | 0.078 | 0 |
| EPS Diluted
| 0.19 | 0.22 | 0.37 | 0.4 | 0.34 | 0.28 | 0.25 | 0.2 | 0.12 | 0.1 | 0.078 | 0 |
| EBITDA
| 121.316 | 129.901 | 144.619 | 158.317 | 134.355 | 109.546 | 71.801 | 59.984 | 36.798 | 20.259 | 7.295 | 2.344 |
| EBITDA Ratio
| 0.073 | 0.088 | 0.098 | 0.122 | 0.178 | 0.169 | 0.121 | 0.114 | 0.11 | 0.092 | 0.045 | 0.025 |